ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,037,000 | -27.5% | 4,250 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $5,568,000 | -25.6% | 4,250 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $7,480,000 | -18.9% | 4,250 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $9,222,000 | -38.0% | 4,250 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $14,875,000 | -64.5% | 4,250 | 0.0% | 0.00% | -75.0% |
| Q1 2021 | $41,905,000 | -40.1% | 4,250 | -34.1% | 0.01% | -46.7% |
| Q4 2020 | $69,918,000 | +1574.3% | 6,450 | +3125.0% | 0.02% | +1400.0% |
| Q2 2020 | $4,176,000 | -85.4% | 200 | -93.2% | 0.00% | -87.5% |
| Q1 2020 | $28,538,000 | – | 2,921 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,043,212 | $46,578,000 | 47.83% |
| Soleus Capital Management, L.P. | 342,800 | $3,949,000 | 3.81% |
| ACUTA CAPITAL PARTNERS, LLC | 1,322,500 | $15,235,000 | 3.77% |
| RTW INVESTMENTS, LP | 6,386,607 | $73,574,000 | 2.78% |
| Ghost Tree Capital, LLC | 1,175,000 | $13,536,000 | 2.58% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $5,530,000 | 2.48% |
| VHCP Management III, LLC | 946,234 | $10,901,000 | 2.16% |
| Avoro Capital Advisors LLC | 5,250,000 | $60,480,000 | 1.78% |
| VHCP Management II, LLC | 383,620 | $4,419,000 | 1.16% |
| Rhenman & Partners Asset Management AB | 650,000 | $7,488,000 | 0.82% |